USANA Health Sciences, Inc. (USNA) to Release Earnings on Tuesday
USANA Health Sciences, Inc. (NYSE:USNA) will be announcing its earnings results after the market closes on Tuesday, July 25th. Analysts expect the company to announce earnings of $1.15 per share for the quarter. USANA Health Sciences has set its FY17 guidance at $3.80-4.10 EPS.
USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $0.91 EPS for the quarter, missing the Zacks’ consensus estimate of $0.92 by $0.01. USANA Health Sciences had a net margin of 9.71% and a return on equity of 31.84%. The firm had revenue of $255.32 million during the quarter. On average, analysts expect USANA Health Sciences to post $3.95 EPS for the current fiscal year and $4.74 EPS for the next fiscal year.
USANA Health Sciences, Inc. (USNA) opened at 63.55 on Tuesday. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00. The stock has a 50 day moving average price of $64.52 and a 200-day moving average price of $60.84. The company has a market capitalization of $1.56 billion, a PE ratio of 16.04 and a beta of 1.13.
In other USANA Health Sciences news, insider Paul A. Jones sold 9,851 shares of the business’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $64.50, for a total value of $635,389.50. Following the completion of the sale, the insider now directly owns 6,020 shares of the company’s stock, valued at $388,290. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Myron W. Wentz sold 40,000 shares of the business’s stock in a transaction on Monday, May 1st. The stock was sold at an average price of $56.39, for a total transaction of $2,255,600.00. The disclosure for this sale can be found here. Insiders have sold a total of 134,735 shares of company stock valued at $8,371,021 over the last ninety days. 53.20% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “USANA Health Sciences, Inc. (USNA) to Release Earnings on Tuesday” was reported by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/07/18/usana-health-sciences-inc-usna-to-release-earnings-on-tuesday.html.
A number of analysts have recently issued reports on USNA shares. Pivotal Research reaffirmed a “hold” rating and set a $55.00 price objective (down from $75.00) on shares of USANA Health Sciences in a report on Monday, May 1st. Zacks Investment Research raised shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Wednesday, April 12th. Finally, BidaskClub downgraded shares of USANA Health Sciences from a “hold” rating to a “sell” rating in a report on Sunday.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.